Inventor · disambiguated record
John P. Duffy
Also filed as: DUFFY JOHN · DUFFY JOHN P · DUFFY JOHN PATRICK
38 granted patents·10 pending applications·783 citations·filing 1995–2020
98Inventor score
Top patents by PatentIndex Score
48 records- 0198US9376448B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Jun 28, 2016·46 cites·10 claims
- 0297US9925188B2DNA-PK inhibitors and uses thereofVERTEX PHARMA·Filed 2016·Granted Mar 27, 2018·24 cites·18 claims
- 0397US5945418AInhibitors of p38VERTEX PHARMA·Filed 1997·Granted Aug 31, 1999·156 cites·25 claims
- 0496US9592232B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Mar 14, 2017·24 cites·13 claims
- 0596US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0696US9394302B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·19 cites·6 claims
- 0796US9051319B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Jun 9, 2015·24 cites·2 claims
- 0895US9296701B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 29, 2016·21 cites·17 claims
- 0995US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 1094US9878993B2DNA-PK inhibitors for treatment of cancerVERTEX PHARMA·Filed 2016·Granted Jan 30, 2018·10 cites·7 claims
- 1194US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 1294US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 1394US8871774B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Oct 28, 2014·18 cites·29 claims
- 1494US6147080AInhibitors of p38VERTEX PHARMA·Filed 1997·Granted Nov 14, 2000·139 cites·18 claims
- 1592US10076521B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 18, 2018·7 cites·21 claims
- 1692US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 1792US9908878B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Mar 6, 2018·8 cites·16 claims
- 1892US8580802B2Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinasesSALITURO FRANCESCO·Filed 2006·Granted Nov 12, 2013·26 cites·26 claims
- 1991US10501439B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Dec 10, 2019·5 cites·18 claims
- 2091US10442791B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Oct 15, 2019·5 cites·13 claims
- 2191US10391095B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Aug 27, 2019·5 cites·9 claims
- 2288US7329652B2Diaminotriazole compounds useful as protein kinase inhibitorsVERTEX PHARAMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·23 cites·15 claims
- 2387US7365072B2Inhibitors of p38VERTEX PHARMA·Filed 2005·Granted Apr 29, 2008·7 cites·23 claims
- 2484US8741912B2Deazapurines useful as inhibitors of Janus kinasesLEDEBOER MARK·Filed 2007·Granted Jun 3, 2014·5 cites·6 claims
- 2583US8633205B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinasesLEDEBOER MARK·Filed 2006·Granted Jan 21, 2014·6 cites·6 claims
- 2682US5843904AInhibitors of interleukin-1βconverting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 1, 1998·51 cites·19 claims
- 2781US7592340B2Quinoxalines useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2004·Granted Sep 22, 2009·23 cites·28 claims
- 2880US7205305B2Inhibitors of p38VERTEX PHARMA·Filed 2003·Granted Apr 17, 2007·9 cites·19 claims
- 2976US11021465B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 1, 2021·0 cites·22 claims
- 3075US11008305B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 3175US8338412B2Inhibitors of P38BEMIS GUY W·Filed 2011·Granted Dec 25, 2012·3 cites·19 claims
- 3274US8937064B2Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitorsLEDEBOER MARK·Filed 2010·Granted Jan 20, 2015·3 cites·2 claims
- 3368US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 3468US8163732B2Tricyclic heteroaryl compounds useful as inhibitors of Janus kinaseBENNANI YOUSSEF·Filed 2009·Granted Apr 24, 2012·1 cites·16 claims
- 3567US2021040092A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2020·Application pending·0 cites
- 3666US7951809B2Inhibitors of p38VERTEX PHARMA·Filed 2008·Granted May 31, 2011·0 cites·14 claims
- 3765US10875855B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·16 claims
- 3865US6608060B1Inhibitors of p38VERTEX PHARMA·Filed 1999·Granted Aug 19, 2003·15 cites·27 claims
- 3964US2009227607A1Deazapurines useful as inhibitors of janus kinasesLEDEBOER MARK·Filed 2008·Application pending·0 cites
- 4063US6162790AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1998·Granted Dec 19, 2000·17 cites·16 claims
- 4161US2010081657A1Quinoxalines useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2009·Application pending·0 cites
- 4261US2014315931A1Deazapurines useful as inhibitors of janus kinasesVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 4357US2014206671A1Tricyclic heteroaryl compounds useful as inhibitors of janus kinaseVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 4455US2012316186A1Deazapurines useful as inhibitors of janus kinasesLEDEBOER MARK·Filed 2012·Application pending·0 cites
- 4555US2012171245A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2011·Application pending·0 cites
- 4652US2014171454A1Substituted Pyrrolo[2,3-d]pyrimidines as Inhibitors of Protein KinasesVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4747US2013090331A1Tricyclic heteroaryl compounds useful as inhibitors of janus kinaseBENNANI YOUSSEF·Filed 2012·Application pending·0 cites
- 4845US2013345218A1Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John P. Duffy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →